Laparoscopic splenectomy has become the gold standard in children

Frederick Rescorla, Scott A. Engum, Karen W. West, L. R Tres Scherer, Thomas M. Rouse, Jay L. Grosfeld

Research output: Contribution to journalArticle

69 Citations (Scopus)

Abstract

Splenectomy is frequently required in children with various hematologic disorders. The reported advantages of laparoscopic Splenectomy (LS) include less pain, shorter hospital stay, and improved cosmesis. This report evaluates the outcome of children undergoing LS at a single children's facility. One hundred twelve children underwent LS by the lateral approach between August 1995 and February 2001. Indications for LS were hereditary spherocytosis in 58, idiopathic thrombocytopenic purpura in 21, sickle cell disease in 19, and other conditions in 14. LS alone was completed in 89 children and LS and cholecystectomy (LSC) in 20. Three required conversion to open Splenectomy. Accessory spleens were identified in 19. Complications included ileus (four), acute chest syndrome (four), bleeding (two), pneumonia (one), and diaphragm perforation (one). There was no mortality. An accessory spleen was missed in one child with recurrent anemia. Average operative time for LS was 106 minutes and for LSC 135 minutes. Operative time for LS decreased with experience but the difference was not significant. Average length of stay was 1.51 days (range 1-11) and was longer in sickle cell disease (2.47 days) versus hereditary spherocytosis (1.29 days) and idiopathic thrombocytopenic purpura (1.16 days). We conclude that LS is safe and effective in children with hematologic disorders and is associated with minimal morbidity, zero mortality, and a short length of stay.

Original languageEnglish
Pages (from-to)297-301
Number of pages5
JournalAmerican Surgeon
Volume68
Issue number3
StatePublished - 2002

Fingerprint

Splenectomy
Hereditary Spherocytosis
Length of Stay
Idiopathic Thrombocytopenic Purpura
Sickle Cell Anemia
Operative Time
Spleen
Acute Chest Syndrome
Mortality
Ileus
Laparoscopic Cholecystectomy
Cholecystectomy
Diaphragm
Anemia
Pneumonia
Hemorrhage
Morbidity
Pain

ASJC Scopus subject areas

  • Surgery

Cite this

Rescorla, F., Engum, S. A., West, K. W., Scherer, L. R. T., Rouse, T. M., & Grosfeld, J. L. (2002). Laparoscopic splenectomy has become the gold standard in children. American Surgeon, 68(3), 297-301.

Laparoscopic splenectomy has become the gold standard in children. / Rescorla, Frederick; Engum, Scott A.; West, Karen W.; Scherer, L. R Tres; Rouse, Thomas M.; Grosfeld, Jay L.

In: American Surgeon, Vol. 68, No. 3, 2002, p. 297-301.

Research output: Contribution to journalArticle

Rescorla, F, Engum, SA, West, KW, Scherer, LRT, Rouse, TM & Grosfeld, JL 2002, 'Laparoscopic splenectomy has become the gold standard in children', American Surgeon, vol. 68, no. 3, pp. 297-301.
Rescorla F, Engum SA, West KW, Scherer LRT, Rouse TM, Grosfeld JL. Laparoscopic splenectomy has become the gold standard in children. American Surgeon. 2002;68(3):297-301.
Rescorla, Frederick ; Engum, Scott A. ; West, Karen W. ; Scherer, L. R Tres ; Rouse, Thomas M. ; Grosfeld, Jay L. / Laparoscopic splenectomy has become the gold standard in children. In: American Surgeon. 2002 ; Vol. 68, No. 3. pp. 297-301.
@article{93f0b4e97fef49339e30c0574953c934,
title = "Laparoscopic splenectomy has become the gold standard in children",
abstract = "Splenectomy is frequently required in children with various hematologic disorders. The reported advantages of laparoscopic Splenectomy (LS) include less pain, shorter hospital stay, and improved cosmesis. This report evaluates the outcome of children undergoing LS at a single children's facility. One hundred twelve children underwent LS by the lateral approach between August 1995 and February 2001. Indications for LS were hereditary spherocytosis in 58, idiopathic thrombocytopenic purpura in 21, sickle cell disease in 19, and other conditions in 14. LS alone was completed in 89 children and LS and cholecystectomy (LSC) in 20. Three required conversion to open Splenectomy. Accessory spleens were identified in 19. Complications included ileus (four), acute chest syndrome (four), bleeding (two), pneumonia (one), and diaphragm perforation (one). There was no mortality. An accessory spleen was missed in one child with recurrent anemia. Average operative time for LS was 106 minutes and for LSC 135 minutes. Operative time for LS decreased with experience but the difference was not significant. Average length of stay was 1.51 days (range 1-11) and was longer in sickle cell disease (2.47 days) versus hereditary spherocytosis (1.29 days) and idiopathic thrombocytopenic purpura (1.16 days). We conclude that LS is safe and effective in children with hematologic disorders and is associated with minimal morbidity, zero mortality, and a short length of stay.",
author = "Frederick Rescorla and Engum, {Scott A.} and West, {Karen W.} and Scherer, {L. R Tres} and Rouse, {Thomas M.} and Grosfeld, {Jay L.}",
year = "2002",
language = "English",
volume = "68",
pages = "297--301",
journal = "American Surgeon",
issn = "0003-1348",
publisher = "Southeastern Surgical Congress",
number = "3",

}

TY - JOUR

T1 - Laparoscopic splenectomy has become the gold standard in children

AU - Rescorla, Frederick

AU - Engum, Scott A.

AU - West, Karen W.

AU - Scherer, L. R Tres

AU - Rouse, Thomas M.

AU - Grosfeld, Jay L.

PY - 2002

Y1 - 2002

N2 - Splenectomy is frequently required in children with various hematologic disorders. The reported advantages of laparoscopic Splenectomy (LS) include less pain, shorter hospital stay, and improved cosmesis. This report evaluates the outcome of children undergoing LS at a single children's facility. One hundred twelve children underwent LS by the lateral approach between August 1995 and February 2001. Indications for LS were hereditary spherocytosis in 58, idiopathic thrombocytopenic purpura in 21, sickle cell disease in 19, and other conditions in 14. LS alone was completed in 89 children and LS and cholecystectomy (LSC) in 20. Three required conversion to open Splenectomy. Accessory spleens were identified in 19. Complications included ileus (four), acute chest syndrome (four), bleeding (two), pneumonia (one), and diaphragm perforation (one). There was no mortality. An accessory spleen was missed in one child with recurrent anemia. Average operative time for LS was 106 minutes and for LSC 135 minutes. Operative time for LS decreased with experience but the difference was not significant. Average length of stay was 1.51 days (range 1-11) and was longer in sickle cell disease (2.47 days) versus hereditary spherocytosis (1.29 days) and idiopathic thrombocytopenic purpura (1.16 days). We conclude that LS is safe and effective in children with hematologic disorders and is associated with minimal morbidity, zero mortality, and a short length of stay.

AB - Splenectomy is frequently required in children with various hematologic disorders. The reported advantages of laparoscopic Splenectomy (LS) include less pain, shorter hospital stay, and improved cosmesis. This report evaluates the outcome of children undergoing LS at a single children's facility. One hundred twelve children underwent LS by the lateral approach between August 1995 and February 2001. Indications for LS were hereditary spherocytosis in 58, idiopathic thrombocytopenic purpura in 21, sickle cell disease in 19, and other conditions in 14. LS alone was completed in 89 children and LS and cholecystectomy (LSC) in 20. Three required conversion to open Splenectomy. Accessory spleens were identified in 19. Complications included ileus (four), acute chest syndrome (four), bleeding (two), pneumonia (one), and diaphragm perforation (one). There was no mortality. An accessory spleen was missed in one child with recurrent anemia. Average operative time for LS was 106 minutes and for LSC 135 minutes. Operative time for LS decreased with experience but the difference was not significant. Average length of stay was 1.51 days (range 1-11) and was longer in sickle cell disease (2.47 days) versus hereditary spherocytosis (1.29 days) and idiopathic thrombocytopenic purpura (1.16 days). We conclude that LS is safe and effective in children with hematologic disorders and is associated with minimal morbidity, zero mortality, and a short length of stay.

UR - http://www.scopus.com/inward/record.url?scp=0036518428&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0036518428&partnerID=8YFLogxK

M3 - Article

C2 - 11894857

AN - SCOPUS:0036518428

VL - 68

SP - 297

EP - 301

JO - American Surgeon

JF - American Surgeon

SN - 0003-1348

IS - 3

ER -